eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Amgen Ltd

240 Cambridge Science Park, Milton Road, Cambridge, CB4 0WD
Telephone: +44 (0)1223 420 305
Fax: +44 (0)1223 426 314
Medical Information Direct Line: +44 (0)1223 436 441
Medical Information e-mail: gbinfoline@amgen.com
Customer Care direct line: +44 (0)808 0100 321
Medical Information Fax: +44 (0)1223 426 314

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 22/02/2012
PIL Mimpara

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
Updated on 12/10/2009 and displayed until 22/02/2012
Reasons for adding or updating:
  • Change to side-effects
Updated on 09/07/2008 and displayed until 12/10/2009
Reasons for adding or updating:
  • Change to date of revision
  • Changes to therapeutic indications
Updated on 06/11/2007 and displayed until 09/07/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 27/04/2006 and displayed until 06/11/2007
Reasons for adding or updating:
  • Change to date of revision
  • Improved Electronic Presentation
Updated on 21/03/2006 and displayed until 27/04/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 18/11/2004 and displayed until 21/03/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   cinacalcet hydrochloride